Table 1 Demographics of the study group
From: Circulating nucleosomes as epigenetic biomarkers in pancreatic cancer
Diagnosis | No. of patients | Median CA 19-9 level | Median age | Male/female |
|---|---|---|---|---|
(range) | (range) | |||
Pancreatic cancer | 25 | 150 kU/l (1.7–1494 kU/l) | 69 (46–78) | 15:10 |
Lymph node involvement | 19 | |||
No lymph node involvement | 6 | |||
Stage IIA | 3 | |||
Stage IIB | 22 | |||
Benign disease | 10 | 31 kU/l (0.6–300 kU/l) | 72 (58–77) | 5:5 |
Chronic pancreatitis | 4 | |||
Intraductal papillary mucinous neoplasms (IPMN) | 2 | |||
Serous cystadenoma | 2 | |||
Tubular adenoma in the ampulla of Vater | 1 | |||
Benign biliary stricture | 1 | |||
Healthy | 24 | 7.3 kU/l (4–20 kU/l) | 58 (48–70) | 15:9 |